martes, 1 de diciembre de 2009
Hematology: percentage of patients aged 18 years and older with a diagnosis of myelodysplastic syndrome (MDS) or an acute leukemia who had baseline cytogenetic testing performed on bone marrow.
TITLE
Hematology: percentage of patients aged 18 years and older with a diagnosis of myelodysplastic syndrome (MDS) or an acute leukemia who had baseline cytogenetic testing performed on bone marrow.
SOURCE(S)
American Society of Hematology, Physician Consortium for Performance Improvement®. Hematology physician performance measurement set. Chicago (IL): American Medical Association (AMA); 2007 Jan. 22 p. [10 references]
abrir aquí para acceder al documento NQMC AHRQ completo:
Hematology: percentage of patients aged 18 years and older with a diagnosis of myelodysplastic syndrome (MDS) or an acute leukemia who had baseline cytogenetic testing performed on bone marrow.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario